Stent-grafts for transjugular intrahepatic portosystemic shunt creation
AbstractObjective. The purpose of this study was to compare clinical results of using an original combined stent construction E-Luminexx + LifeStream and a Hanarostent graft for transjugular intrahepatic portosystemic shunting (TIPS).
Patients and methods. We retrospectively analyzed the results of treating a total of 89 patients after a TIPS procedure using either a combined stent construction E-Luminexx + LifeStream or a Hanarostent graft. The study included 44 men and 45 women, average age 54.4±10.1 years (range 33–71). The patients were divided into two groups: Group I consisted of 50 (56.2%) patients subjected to the TIPS procedure using the stent construction E-Luminexx + LifeStream and Group II comprised 39 (43.8%) patients treated with the Hanarostent graft.
Results. According to Kaplan-Meier analysis, cumulative primary patency in Group I and Group II patients at 1, 6, 24 and 48 months amounted to 93.9%, 91.8%, 81.5% and 73.1 vs 89.7, 81.8, 65,2 and 46.6%, respectively.
Conclusion. A comparative analysis of the short- and long-term results of TIPS created by means of the combined construction E-Luminexx + LifeStream and the Hanarostent revealed good comparable 12-month primary patency (85.3 vs 76.6%).
Funding. The study had no financial support.
Conflict of interest. The authors declare no conflicts of interest.
Authors’ contribution. Study conception and design – Zatevakhin I.I., Shipovskiy V.N., Tsitsiashvili M.Sh., Monakhov D.V., Zabadaeva O.B.; data collection and handling – Zatevakhin I.I., Shipovskiy V.N., Tsitsiashvili M.Sh., Monakhov D.V., Zabadaeva O.B.; statistical processing – Zabadaeva O.B.; draft manuscript preparation – Zatevakhin I.I., Shipovskiy V.N., Tsitsiashvili M.Sh., Monakhov D.V., Zabadaeva O.B.; manuscript revision – Zatevakhin I.I., Shipovskiy V.N., Tsitsiashvili M.Sh., Monakhov D.V., Zabadaeva O.B.
For citation: Zatevakhin I.I., Shipovskiy V.N., Tsitsiashvili M.Sh., Monakhov D.V., Zabadaeva O.B. Stent-grafts for transjugular intrahepatic portosystemic shunt creation. Angiology and Vascular Surgery. Journal named after Academician A.V. Pokrovsky. 2024; 30 (1): 73–9. DOI: https://doi.org/10.33029/1027-6661-2024-30-1-73-79
Keywords:portal hypertension; TIPS; E-Luminexx + LifeStream; Hanarostent
Dear readers!
Full-text version of the article is available only in paper version.